ABOUT US
gSpin is focused on powering medical diagnostic devices with our patented non-invasive technology. The three medical devices gSpin is focused on are glucose monitoring, MRI systems and blood metabolic profiling and monitoring. All devices will be non-invasive and in vivo. gSpin has developed an MRI head coil prototype that is both bench and scanner tested, using both phantom and cadavers. The result thus far show as much as 4X SNR enhancement. Continued development based on our current models can enhance by as much as a factor of 10 to a factor of 20. Key to this development is that this enhancement is room temperature without the use of cryogenics. Moreover, it will seamlessly integrate into current scanners with minimal brand customization. Operators and MRI technologists would not require training on our device; it can be used as any other MRI add-on.
The methodology developed at gSpin can enhance signals globally, noninvasively and in real time. Moreover, gSpin’s technology platform has broad applicability and can be used in other technological modalities. Competitor technologies use diamond-based sensors and achieve similar enhancement but are limited to either surface application or require the injection or ingestion of a signal enhancing agent. gSpin’s technology aims to produce results globally and without invasive agents of any kind.
OUR TECHNOLOGY
The second quantum revolution is credited as driving such novel inventions as the quantum computer. Underpinning this development is the direct manipulation of elementary or quantum interactions between particles such as electrons and protons within atoms and molecules. In many of these settings, to reach and access these interactions requires specialized environments such as extremely low temperatures or very high vacuums.
A perennial goal of medical diagnostics is to obtain an enhanced, or the highest sensitivity possible in the detection of biological cells and tissues. In the past, often this involved minimizing or suppressing the detection and environmental noise. Some developments addressed the signal sensitivity by improving the detection mechanisms. More recently, many researchers are using AI and machine learning algorithms in addition to new image processing techniques to further enhance and speedup detection sensitivity and specificity.
gSpin Technologies has taken a completely different approach and is using the new quantum technological developments to enhance detector sensitivity at the molecular interaction level. We have discovered a new method to enhance detector sensitivity by directly manipulating the detector coupling to the detected tissue or cells. Using this method, we find that it has broad applicability beyond the medical diagnostics field and can serve as a platform to be used in many different fields and disciplines. However, our focus presently is on medical diagnostics.
GOAL
Develop medical diagnostic devices that are:
Ultra-sensitive
Non-invasive
Dynamic
Real-time
Their intended use can be in any of the following settings:
Clinical
Tabletop for laboratory or mobile use
End-user
METHODS
gSpin’s proprietary and very novel technology is based on the use of quantum technologies that enable direct manipulation of intrinsic cellular signals to allow achieving the stated goals above.
OUTCOME
Patents filed
Product demonstration and proof-of-concept experiments on-going. If you would like to set up a demonstration of our quantum sensors please get in touch.
Our innovation lead and co-founder is Grum Teklemariam, a foremost expert in MRI technologies and quantum enabled diagnostic devices. He was formerly CTO & co-founder of XBo Medical Systems in China and CEO & co-founder of High Q Technologies in Canada. Based on his thirty years of magnetic resonance and quantum computing expertise, he developed gSpin’s broad technological platform for signal enhancement at the molecular level. Grum is co-inventor on 10 issued patents and several more pending patents. He also has about 20 published articles and journals. Grum is a graduate of MIT with a PhD in physics in 2002.
